-transparent.png){kind=logo}
Direct antitumor effect of cepharanthin (CEP) and the combined effect with adriamycin (ADR), as well as the effect of CEP against body weight loss caused by treatment of ADR were evaluated using ICR mice bearing Ehrlich ascites tumor. Single administration of CEP reduced tumor growth compared to that of the untreated control, but not significantly. However, multiple administration of CEP reduced the tumor growth significantly compared to that of the untreated control (p < 0.001). Simultaneous administration of intratumoral CEP and intravenous ADR reduced the tumor growth significantly compared to that of ADR alone (p < 0.05). Further, CEP restored body weight loss caused by the treatment of ADR (p < 0.01). These findings indicate that the combined administration of CEP and ADR may be effective in cancer treatment.
J Asaumi, and
K Nishikawa, and
H Matsuoka, and
M Iwata, and
S Kawasaki, and
Y Hiraki, and
K Nishijima
March 1988,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
J Asaumi, and
K Nishikawa, and
H Matsuoka, and
M Iwata, and
S Kawasaki, and
Y Hiraki, and
K Nishijima
June 1986,
Chemical & pharmaceutical bulletin,
J Asaumi, and
K Nishikawa, and
H Matsuoka, and
M Iwata, and
S Kawasaki, and
Y Hiraki, and
K Nishijima
April 1980,
Japanese journal of pharmacology,
J Asaumi, and
K Nishikawa, and
H Matsuoka, and
M Iwata, and
S Kawasaki, and
Y Hiraki, and
K Nishijima
January 1996,
Anticancer research,
J Asaumi, and
K Nishikawa, and
H Matsuoka, and
M Iwata, and
S Kawasaki, and
Y Hiraki, and
K Nishijima
January 1980,
L'Ateneo parmense. Acta bio-medica : organo della Societa di medicina e scienze naturali di Parma,
J Asaumi, and
K Nishikawa, and
H Matsuoka, and
M Iwata, and
S Kawasaki, and
Y Hiraki, and
K Nishijima
January 1995,
Biological & pharmaceutical bulletin,
J Asaumi, and
K Nishikawa, and
H Matsuoka, and
M Iwata, and
S Kawasaki, and
Y Hiraki, and
K Nishijima
January 1971,
Mie medical journal,
J Asaumi, and
K Nishikawa, and
H Matsuoka, and
M Iwata, and
S Kawasaki, and
Y Hiraki, and
K Nishijima
July 2013,
Pharmaceutics,
J Asaumi, and
K Nishikawa, and
H Matsuoka, and
M Iwata, and
S Kawasaki, and
Y Hiraki, and
K Nishijima
December 1968,
Medical journal of Osaka University,
J Asaumi, and
K Nishikawa, and
H Matsuoka, and
M Iwata, and
S Kawasaki, and
Y Hiraki, and
K Nishijima
February 1971,
Harefuah,
